Gossamer Bio Shares Jump 15%

Shares of Gossamer Bio, Inc. (GOSS) are gaining over 15% on Monday morning despite no stock-specific news to drive the shares.

GOSS is currently trading at $13.80, up $1.93 or 16.26%, on the Nasdaq. The stock has traded between $7.04 and $14.09 in the 52-week period.

Gossamer Bio is a clinical-stage biopharmaceutical company that is focused on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States.

Last week, Gossamer Bio announced that Bryan Giraudo has been appointed Chief Operating Officer, in addition to his continued role as Chief Financial Officer. Giraudo joined Gossamer in May 2018 as its Chief Financial Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Follow RTT